Many of society’s energy challenges require gigawatts of power, but many more are small – and some are entirely microscopic. To drive a new generation of tiny micromachines that could deliver drugs or clean traces of pollution, physicists are increasingly looking to biology for inspiration.
In work published in the journal Science Advances,
my co-authors and I present a simulation of a sort of tiny “windfarm”
powered by the natural self-organisation of bacteria. It’s a small step
towards harnessing the energy potential of microorganisms.
Active fluid-powered windfarms
We used computer simulations to model many swimming bacteria, such as the E. coli
you find in your gut. A dense crowd of these swimming bacteria isn’t
too different from traditional, passive liquid, though there’s one major
exception: it spontaneously flows, with internal whirling currents.
Physicists have started calling anything that spontaneously flows in
this way an “active fluid”. It looks something like this: A dense group of E. coli swimming around … randomly?
We first placed a solitary disc-shaped rotor in the midst of these
chaotic swirling jets. Since the rotor was pinned in place but free to
rotate, the turbulence randomly spun it in all directions, like a
weather vane in a hurricane.
However, when we included an entire array of closely arranged rotors
on a grid, we saw something more interesting happen. Mimicking more
complex biological self-organisation, the rotations spontaneously
organised, with each rotor spinning in the opposite direction of its
neighbour. When placed in the bacteria, rotors began to spin in alternating directions.Tyler Shendruk, Author provided
Every single rotor in our simulation permanently obeyed the pattern,
as long as they were close enough together and a whirl of bacterial
fluid was trapped around each one. This orderly spinning reminded us of a
microscopic wind farm, powered not by gusts but by the surrounding
bacteria.
So what was going on?
Without the rotors, the chaotic swirls of the bacterial flows
randomly whirl in all directions. But when we added the rotors, they got
in the way of this disordered mess.
Since the swirls couldn’t really fit well between the two rotors, the
bacteria started whirling around and around each rotor. In a way, the
rotors became the mechanical heart of each swirling jet of bacteria.
They anchored the swirls in place and, in return, the bacteria
permanently organised the spinning of the rotors.
The bacteria and the rotors form a partnership and out of that
cooperation an organised pattern spontaneously occurs. Physicists call
this natural emergence of a pattern “self-assembly”. Self-assembly is
when simple building blocks organise themselves into complex structures
or self-heal. It is spontaneous but orchestrated action.
Nowhere is self-assembly more evident than in developing tissues,
where cells move collectively into a part of an organism. Striking
examples of this multicellular cooperation include gastrulation, an
early step in an embryo’s development from a group of cells into a
fully-fledged organism; or Volvox inversion, in which a colony of
single-celled algae flips inside out. But these examples are both purely biological.
Microscopic cyborgs
Our virtual prototype shows one specific case of a biological active
fluid interacting with simple, man-made components. The fact that both a
biological active fluid and tiny microengineered rotors are needed to
get this ordering highlights how nature has already evolved incredibly
efficient active materials that we could harness for hybrid
bio-mechanical machines.
In fact, many of us physicists are already working on systems that
involve both biology and micro-mechanical components that come together
to self-organise. For instance, scientists have just developed a
ray-like swimming robot with a microfabricated skeleton and a rubber
body that is powered by heart muscle cells.
That’s the long-term goal: to build tiny machines that don’t struggle
against biology, but instead work seamlessly with or even depend on it.
Our ability to engineer the microscopic world is an exciting prospect
for the future
As antibiotic resistance increases the search for new anti-bacterial treatments becomes more and more important. One way to design anti-bacterials is to find specific biochemical pathways that the bacteria require to survive, and develop drugs that block off these pathways. Some pathways are better targets than others and for Salmonella bacteria it was thought that pathways dealing with nutrient metabolises would be a lost cause. Salmonella lives in the intestine, which hosts a whole variety of different nutrients, so surely preventing the bacteria from using a specific one wouldn’t cause them much undue distress. It’s been found, however, that as they grow and spread in the inflamed intestine the bacteria are heavily reliant on one particular nutrient: fructose-asparagine. The chemical structure of fructose-asparagine, image from the reference. The importance of fructose-asparagine metabolism was originally discovered durin...
Enterotoxigenic Escherichia coli (ETEC) is known as a major cause of diarrhea in travelers and people living in developing countries. According to the World Health Organization (WHO), ETEC is responsible for 300,000 ~ 500,000 deaths a year, constituting a serious problem. Effective vaccines for ETEC have not been developed, so patients infected with ETEC are treated with antibiotics and supporting measures. However, the emergence of multidrug-resistant bacteria has become a social issue, so the development of new treatment methods is sought after. Adherence to the host intestinal epithelium is an essential step for ETEC infection in humans. It was thought that a filamentous structure on the surface of bacteria called 'type IV pilus' was important for bacterial attachment, but its detailed adhesion mechanism was not known. Osaka University-led researchers clarified how pathogenic E.coli attached to the host intestinal epithelium using type IV pili and secre...
Research by a team led by Dr Elizabeth Fullam, has revealed new findings about an enzyme found in Mycobacterium tuberculosis (Mtb) the bacterium that causes TB. TB causes more deaths than any other infectious disease, including from HIV and malaria. In 2016 there were 10.4 million new cases of TB and 1.7 million people died. The rise in cases of TB that are resistant to the current therapies that are available means that there is an urgent need to develop new TB therapeutics. Mtb is a highly unique bacterium and is enclosed within a distinctive cell wall that is comprised of unusual sugars and lipids which protect the bacteria from the host environment. Disruption of essential pathways involved in the assembly of the Mtb cell wall is an attractive approach for new TB drugs. The team found a key structural motif in the tuberculosis N-acetylglucosamine-6-phosphate deacetylase (NagA) enzyme. Attacking this structural motif through the design and exploitation of new mol...
Comments
Post a Comment